Congratulations, MBX Biosciences, Inc., on their US$63.5 million Series C raise! We're excited to continue to support their novel precision peptide therapies that can improve the standard of care for the treatment of endocrine and metabolic disorders.
Wellington Management Private Investing
Financial Services
Boston, Massachusetts 10,154 followers
About us
For almost 100 years, we have chosen to do things differently, including the way we structure our ownership model, organization, and investment platform. Critically, we know that the best investment ideas are found when a diverse workforce is encouraged to bring forward unique perspectives. Wellington Management is one of the world’s largest independent investment management firms, serving as a trusted adviser to over 2,400 clients in more than 60 countries. We manage more than US$1 trillion for pensions, endowments and foundations, insurers, family offices, fund sponsors, global wealth managers, and other clients. As a private partnership whose only business is investment management, we are able to align our long-term views and interests with those of our clients. We offer comprehensive investment management capabilities that span nearly all segments of the global capital markets, including global equity, fixed income, currency, commodity, alternatives, and private markets. The Wellington Private Investing platform has a dedicated team that invests across multiple sectors and stages of the private markets and leverages the firm’s more than 1,000 investment professionals located in offices around the world. From early-stage venture to late-stage growth, the team actively invests in the next generation of industry defining entrepreneurs and changemakers. The team has raised over US$8.0 billion in global assets to invest across geographies (Asia, Europe, and the Americas) and sectors (consumer, technology, health care, financial services, biotechnology, climate technology, and more). Wellington’s dedicated Private Investing team takes a long-term perspective and provides both investors and entrepreneurs access to its depth of expertise in the public and private markets, extensive network, and robust research across its global footprint. For more information about Wellington Private Investing, please visit wellington.com/privateinvesting
- Website
-
https://www.wellington.com/privateinvesting
External link for Wellington Management Private Investing
- Industry
- Financial Services
- Company size
- 1,001-5,000 employees
- Headquarters
- Boston, Massachusetts
- Founded
- 1933
- Specialties
- private equity, private investments, private markets, investment management, alternative investing, and venture capital
Updates
-
Read the WSJ's new feature on Abnormal Security's US$250 million Series D round led by Wellington Management. In the article, Rob Mazzoni, technology sector lead for late-stage private investments, shares why he believes Abnormal's #AI cybersecurity technology is critical: "The scale at which attacks can be launched through automation means that human analysts are unlikely to keep up as the technology develops and proliferates." https://lnkd.in/eUHMJXv3
-
"We're thrilled to be leading Abnormal Security's US$250 million round as the company sets it sights on the public market," said Rob Mazzoni, Technology Sector Lead for late-stage private investments. In Rob's view, Abnormal's platform is "well-positioned to address the vast human behavior and identity-centric cybersecurity challenges we're facing today."
Abnormal Security Announces $250M Series D at $5.1B Valuation
abnormalsecurity.com
-
Congratulations, TS Conductor , on a US$60 million oversubscribed fundraise! We’re enthusiastic to lead this growth round – partnering with leaders like Breakthrough Energy Ventures , National Grid Partners, Quanta Services, Inc., Edison International, Blue Earth Capital AG, @Gates Frontier, Energy & Environment Investment, Inc., and a subsidiary of NextEra Energy Resources – to help the company scale production and meet rising customer demand. “Decarbonizing the energy sector hinges on resolving electric grid bottlenecks, and we believe TS Conductor’s technology unlocks cost-effective and fast capacity additions,” said Michael DeLucia, sector lead for private climate investing. https://lnkd.in/ghr5-YaX
TS Conductor raises $60 million from industry-leading investors to expand US production of high-capacity power lines
prweb.com
-
Did you know? Only 21% of companies have AI risk management policies in place. Dive into our latest research on #AIGovernance to learn best practices for private companies: https://lnkd.in/d3WVJskH Source: QuantumBlack AI by McKinsey. “The state of AI in 2023: Generative AI’s breakout year,” 1 August 2023.
AI governance for private companies
wellington.com
-
There are so many (climate) solutions that are ready to scale right now or just need a bit of help getting to market. That’s where we can add a lot of value as a partner,” says head of private climate investing, Greg Wasserman, in Preqin’s recent Q&A. To hear more of his insights on climate venture investing, read the full article. https://lnkd.in/dNdmJV8N
-
Did you know the average cost of a data breach in 2023 was ~US$4.45 million per incident? Learn why cybersecurity is particularly relevant for private companies and explore best practices for firms facing these threats. Source: IBM, “Cost of a Data Breach 2023.”
Private equity cybersecurity & data transparency
wellington.com
-
In Forbes' recent profile of Element Biosciences' US$277 million fundraising round, led by Wellington, health care sector lead Joshua Sommerfeld highlighted how Element’s technical differentiation, flexible workflow, and move into multi-omics are key drivers of their long-term potential. Read the full article to learn more about Element's potential to accelerate biological discovery.
Element Biosciences Raises Over $277 Million to Develop and Commercialize Differentiated Products and Continue Rapid Growth
prnewswire.com
-
Kudos to Grace Reyes and team for the terrific The Investment Diversity Exchange (TIDE) SPARK 2024 conference in Dana Point, CA. The conference featured a phenomenal mix of LPs and GPs and excellent panel sessions - from early-stage opportunities with underrepresented founders to democratizing access to alternatives. Christine Fleming, Nelson McNeil, Jason A. Horowitz
-
We’re proud to announce our lead investment in Element Biosciences’ oversubscribed US$277 million Series D fundraising round. “After years of watching Element’s impressive progress from the sidelines, we are excited to support the company’s next chapter of growth and development,” said Joshua Sommerfeld, health care sector lead for our Late-Stage Growth private investments. "Their platform combines quality, cost, and flexibility advantages that disrupt the incumbent price curve. By bringing end-to-end integrated multi-omic workflows onto a single system, Element has potential to accelerate biological discovery.”
Element Biosciences Raises Over $277 Million to Develop and Commercialize Differentiated Products and Continue Rapid Growth
prnewswire.com